Ozone therapy is a gas that can reduce inflammation and help with pain relief short term, but stem cells are regenerative a long lasting.
Peptides are chemicals. Some are good for you and may be complimentary to stem cell treatment. However, some can be carcinogenic and should not be used.
Exosomes are small vesicles that are released by cells in your body. To our knowledge, exosomes are closely related to cancer and how it spreads through your body. We do not use exosomes for that reason.
PRP is platelet-rich plasma. The platelets have factors that stimulate stem cells that are already in your body. It is a regenerative treatment and a biological treatment but is not the same, nor is it as strong as a treatment using our stem cell therapy.
301 N. Canon Drive, Suite 305
Beverly Hills, California 90210
© 2026 | BH Cellular Medicine | All Rights Reserved. All content and images are property of Cristina Bertolotto, MD and cannot be saved or duplicated without expressed written consent.
DISCLAIMER: The information provided on this website is for general educational purposes only and is not medical advice. Any references to cellular or regenerative approaches describe areas of ongoing scientific and clinical research. Except where specifically identified as an FDA‑approved product, the cellular procedures discussed on this website have not been evaluated or approved by the US Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or condition. FDA has stated that stem cell products and products derived from adipose tissue of the type described here have not been approved to treat orthopedic, neurologic, cardiopulmonary, autoimmune, or other chronic conditions.(fda.gov)
Any cellular procedure carries potential risks, and benefits are uncertain. Decisions about care should be made in consultation with a licensed healthcare professional who can review all conventional and investigational options. BH Cellular Medicine endeavors to operate in compliance with applicable US laws and regulations governing human cells, tissues, and cellular and tissue‑based products (HCT/Ps), including requirements under section 361 of the Public Health Service Act and 21 CFR Part 1271, where applicable.(fda.gov)
PHOTO CITATION: Image source: Nature Reviews Endocrinology, March 2010 issue. File name: “NATURE-ENDOCRINOLGY-BH-CELLULAR-1920px.png”.
